期刊文献+

基底膜蛋白多糖的功能多样:血管发生与软骨形成及软骨骨化

Multi-functional perlecan: angiogenesis, chondrogenesis and chondrosteosis
下载PDF
导出
摘要 背景:基底膜蛋白多糖功能多样,在调节血管生物学行为和损伤修复中具有重要作用。目的:探讨基底膜蛋白多糖在组织发育、血管发生、软骨形成中的调节机制。方法:应用计算机检索Sciencedirect和中国生物医学文献数据库(2000-01/2010-12),检索词分别为"perlecan,angiogenesis,cartilage,heparan sulfate,vascular endothelial growthfacto"和"基底膜蛋白多糖,血管,软骨,硫酸乙酰肝素,血管内皮生长因子"。纳入与基底膜蛋白多糖的表达、功能密切相关,同一领域选择近期发表或在权威杂志发表的文章。排除重复性研究或Meta分析类文章。结果与结论:检索到129篇文献,按纳入及排除标准筛选后,共纳入35篇符合标准的文献。经分析得出以下结论:基底膜蛋白多糖在机体发育过程必不可少,其具体作用机制受细胞微环境的影响。基底膜蛋白多糖功能强大,在与生长因子、成形素、基质蛋白交互作用下,可用相同的机制来调节每一个程序。 BACKGROUND:Perlecan functions in a diverse range which ranges from the regulation of cell growth and adhesion to extracellular matrix assembly. We previously identified a central function for perlecan during angiogenic blood vessel development and injury restoration. OBJECTIVE:To explore the mechanism of perlecan in tissue development and organogenesis. METHODS:A computer-based retrieval was performed to search manuscripts published between January 2000 and December 2010 in Sciencedirect and CMCC/CMCI with key words of"perlecan, angiogenesis, cartilage, heparan sulfate, vascular endothelial growth factor."The manuscripts with the contents of perlecan expression and function published recently or in authoritative journals were included. Manuscripts with repetitive contents or Meta analysis were excluded. RESULTS AND CONCLUSION:A total of 129 manuscripts were included, and according to inclusion and exclusion criteria, 35 manuscripts were included in the final analysis. Perlecan plays a crucial role in tissue development.The underlying mechanism is possibly due to the interactions of the pericellular environment. Perlecan functions in a diverse range. Perlecan employs the same basic mechanism, based on interactions with growth factors, morphogens and matrix proteins.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第37期7000-7004,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金(30770572)资助 名称:应用重组PlnDI构建自组装促血管发生材料~~
  • 相关文献

参考文献35

  • 1Whitelock JM,Iozzo RV.Heparan sulfate:a complex polymer charged with biological activity.Chem Rev.2005;105:2745-2764.
  • 2Costell M,Carmona R,Gustafsson E,et al.Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice.Circ Res.2002;91:158-164.
  • 3Davis GE,Senger D R.Endothelial extracellular matrix:biosynthesis,remodeling,and functions during vascular morphogenesis and neovessel stabilization.Circ Res.2005;97:1093-1107.
  • 4Zoeller JJ,Whitelock JM,Iozzo RV.Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.Matrix Biology.2009;28(5):284-291.
  • 5Aviezer D,Hecht D,Safran M,et al.Perlecan,basal lamina proteoglycan,promotes basic fibroblast growth factor-receptor binding,mitogenesis,and angiogenesis.Cell.1994;79:1005-1013.
  • 6Gonzalez EM,Mongiat M,Slater SJ,et al.A novel interaction between perlecan protein core and progranulin:potential effects on tumor growth.J Biol Chem.2003;278:38113-38116.
  • 7Savore C,Zhang C,Muir C,et al.Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.Clin Exp Metastasis.2005;22:377-390.
  • 8Knox S,Merry C,Stringer S,et al.Not all perlecans are created equal:interactions with fibroblast growth factor (FGF) 2 and FGF receptors.J Biol Chem.2002;277:14657-14665.
  • 9Knox S,Fosang AJ,Last K,et al.Perlecan from human epithelial cells is a hybrid heparan chondroitin/keratan sulfate proteoglycan.FEBS Lett.2005;579:5019-5023.
  • 10Zhou Z,Wang J,Cao R,et al.Impaired angiogenesis,delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.Cancer Res.2004;64:4699-4702.

二级参考文献15

  • 1Arikawa-Hirasawa E,Le AH,Nishino I,et al.Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome,with myotonic myopathy and chondrodysplasia[J].Am J Hum Genet,2002,70(5):1368-1375
  • 2Segev A,Nili N,Strauss BH,et al.The role of perlecan in arterial injury and angiogenesis.[J].Cardiovasc Res,2004,63(3):603-610
  • 3Costell M,Gustafsson E,Aszodi A,et al.Perlecan maintains the integrity of cartilage and some basement membranes[J].J Cell Biol,1999,147(5):1109-1122
  • 4Arikawa-Hirasawa E,Wilcox WR,Yamada Y,Dyssegmental dysplasia,Silverman-Handmaker type:Unexpected role of perlecanin cartilage development[J] Am J Med Genet,2001,106(8):254-257
  • 5Line SR.Molecular morphogenetic fields in the development of human dentition[J].J Theor Biol,2001,211(1):67-71
  • 6lMatalova E,Tucker T,sharpe T,et al.Death in the life of tooth[J].J Dent Res,2004,83(1):11-18
  • 7Liu Z,Xu J,Colvin JS,et al.Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18[J].Genes Dev,2002,16(4):859-869
  • 8Iozzo RV,Cohen IR,Grassel S,et al.The biology of prelecan:the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices[J].Biochem J,1994,302(3):625-639
  • 9Arikawa-Hirasawa E,Le AH,Nishino I,et al.Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome,with myotonic myopathy and chondrodysplasia[J].Am J Hum Genet,2002,70:1368-1375.
  • 10Iozzo RV,Cohen IR,Grassel S,et al.The biology ofperlecan:The multifaceted heparan sulphate proteoglycan ofbasementmembranes and pericellular matrices[J].Biochem J,1994,302:625-639.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部